Depression is the most common professionally and self diagnosed psychiatric condition. There are many theoretical explanations for what it is and how it develops, from genetic predisposition, to neurochemical deficiencies, physiological responses such as miscommunication between brain cells1, life situation and experience, trauma, diet, and addiction.
However, there doesn’t seem to be a comprehensive way to confirm a clinical diagnosis, and a growing number of medical professionals and former psychiatrists have been begun to advocate that there is enough known about the condition for psychiatric medication to be an effective, or even safe, treatment2.
What seems most clear is that the feelings of having little or no enthusiasm about most things in life, changes in appetite, sleep, and a general inability to practice habits of self-care, confusion, memory loss, and other things that people associate with depression, can be complex and challenging.
In order to manage similar symptoms, millions of Americans, and a growing number of people around the world, take SSRI’s anti-depressants and other psychiatric medications. The withdrawal symptoms associated with stopping the use of SSRI anti-depressants can be protracted, and intolerable for many, and there are even class action lawsuits against makers of certain anti-depressants.
Our protocol for depression has two main components. On one hand, we have been able to successfully treat many individuals who decided to stop taking anti-depressants but couldn’t on their own, with a marked decrease in withdrawal symptoms. On the other, we have a protocol designed to treat the underlying depression itself.
Ibogaine has been shown to have positive results for depressive symptoms, at least in the short term3. However, we’ve also seen people, after a single flood dose of ibogaine, left with depressive symptoms, especially in cases where the condition is chronic.
Ibogaine alone cannot treat depression. There are fundamental neurochemical factors that need continued support. For that reason, we’ve expanded our protocols to include meditation, exercise, a number of adjunct therapies, brain training, and thorough nutritional support, including supplements like SAMe4, St. John’s wort5, Omega-3 fatty acids6, 5-HTP7, and vitamin D.
Many of these things can help, no matter how prepared a client is for treatment, and we offer our pre-care protocol to anyone who wants to start to improve their mind and body wellness immediately.
Ibogaine: Complex Pharmacokinetics, Concerns for Safety, and Preliminary Efficacy Measures, Mash DM, Neurobiological Mechanisms of Drugs of Abuse, Volume 914, September 2000 – Full Text ↩
Fighting Depression and Improving Cognition with Omega-3 Fatty Acids, Laurie Barclay, MD, October 2007 ↩
Are SAMe and 5-HTP safe and effective treatments for depression?, Young S, November 2003 ↩